Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in cerebellar syndrome secondary to multiple sclerosis.

Source:http://linkedlifedata.com/resource/pubmed/id/14586600

Download in:

View as

General Info

PMID
14586600